ENTITY
Ilyang Pharmaceutical Co.,

Ilyang Pharmaceutical Co., (007570 KS)

35
Analysis
Health Care • South Korea
Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system. The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food, insecticides, cosmetics, pharmaceutical raw materials, and therapeutic agents for liver and kidney disease.
more
bullish•SeAH Besteel Holdings
•07 Jun 2021 11:30

KOSPI200 Index Rebalance Preview: Focus Shifts to December After a Fantastic June Review

We see 1 potential change in September and 3 potential changes at the KOSPI200 December review. Post the excellent returns at the June rebalance,...

Logo
580 Views
Share
bullish•Hanjin KAL Corp
•01 Mar 2020 12:14

KOSPI200 Rebalance Preview - Changing Names in a Volatile Market

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
548 Views
Share
bullish•Posco Future M
•10 Feb 2020 13:01

KOSPI200 Rebalance Preview - The Early Bird Gets the Worm

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSPI 200 in May. The constituent changes will be effective from...

Logo
680 Views
Share
bearish•Celltrion Inc
•10 Aug 2017 19:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.7k Views
Share
x